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We previously have shown that two latency-associated transcripts (LATs) of herpes simplex type 1 (HSV-1) are probably
lariats, produced during splicing. By RNaseH digestion analysis, we now show that the major branchpoint of the 2.0-kb LAT
was within 46 nt 59 of the splice acceptor site. A more detailed mapping by primer extension revealed the branchpoint as an
adenosine 29 nt 59 of the splice acceptor site. Introduction of two branchpoint sequences with good matches to the
consensus at position 225 had no effect on the splicing efficiency but reduced the accumulation of the 2.0-kb LATs at least
90-fold. The second focus of our studies was the 1.5-kb LAT. It was not detected by Northern analyses in either productively
infected or transfected cultured cells or even in cells of neuronal origin. However, it was detected in the trigeminal ganglia
of mice experimentally infected with HSV-1 after 10 days. Moreover, its abundance relative to that of the 2.0-kb species
increased 4-fold from 10 to 30 days after infection, consistent with an interpretation that the 1.5-kb species, once formed, was
more stable than the 2.0-kb species. © 1998 Academic Press
INTRODUCTION
During latent infections with herpes simplex virus type
1 (HSV-1) there is an accumulation of discrete-sized
species which are known as latency-associated tran-
scripts or LATs. The biological significance, if any, of
these LATs is still a controversial issue (Fraser et al.,
1992). However, at the RNA-processing level, it is in-
ferred that the 2.0- and 1.5-kb LATs correspond to intron
sequences. The 2.0-kb LAT region is spliced out of HSV-1
sequences expressed in transfected cells (Farrell et al.,
1991; Spivack et al., 1991). In addition to the 2.0-kb LAT,
the 1.5-kb LAT is also found in latently infected trigeminal
ganglia (TGG) of mice. This smaller species represents a
spliced version of the 2.0-kb species from which a 0.5-kb
intron is removed (Spivack et al., 1991). It has been
suggested that removal of the 0.5-kb intron might allow
the translation of important open reading frames (Spiv-
ack et al., 1991) but this remains a controversial issue
(Roizman and Sears, 1996). Recent studies show that
both LATs are in a nonlinear conformation (Wu et al.,
1996; Rodahl and Haarr, 1997). It is interpreted that these
are actually lariat structures produced during splicing
but which, for some reason, fail to go on to the typical
debranching. Debranched lariats are normally promptly
and efficiently degraded with half-lives of only seconds
(Sharp et al., 1987).
The initial aim of the present study was to better
understand the basis for the accumulation of LATs. Our
experimental strategy, similar to that of Farrell et al.
(1991), was to express the HSV-1 LAT sequences in
transfected cells using an eukaryotic expression vector.
We first made a speculation as to the branchpoint nu-
cleotide for the LATs and hypothesized that its poorly
matched branchpoint sequence to the consensus was
the cause for inefficient debranching. We then intro-
duced mutations to improve the match of this predicted
branchpoint sequence to the consensus and asked
whether the 2.0-kb LAT accumulated. Next, to test the
predicted branchpoint nucleotide, we used oligonucle-
otide-directed RNaseH digestion and primer extension.
Finally, since little is known about the origin of the 1.5-kb
LAT, we also studied its expression in transfected or
virus-infected cultured cells as well as in virus-infected
mice.
RESULTS
Expression of a 2.4-kb HSV-1 cassette in transfected
Huh7 cells
Previous studies with transfected cells have defined
the splice donor and acceptor sequences used in the
splicing of the 2.0-kb LAT but not the branchpoint (Farrell
et al., 1991). We previously predicted the branchpoint to
be the adenosine 25 nt 59 of the splice acceptor site (Wu
et al., 1996). The basis for this prediction was that the
major determinants for selection of a branchpoint nucle-
otide are the proximity to a polypyrimidine tract and the
homology to a consensus branchpoint region (Moore et
al., 1993) of a 7-nt flanking sequence, including the
branchpoint nucleotide, which is typically adenosine. As
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indicated in Fig. 1A, 59 of the known splice acceptor for
the LAT sequence are 19 pyrimidine nucleotides with the
interruption of only 1 guanosine. The nearest adenosines
adjacent to this tract are at positions 225 and 229.
Compared to the 7-nt consensus branchpoint sequence
(Fig.1A), the flanking sequence (224 to 230) of the aden-
osine at 225, is only a 3/7 match and that (228 to 234)
of the more distant adenosine at position 229 is a
slightly better 4/7 match. Since these two potential
branchpoint sequences both have poor matches to the
consensus branchpoint region, we thus predicted the
branchpoint to be the adenosine at position 225, based
on the observation that the adenosine closer to the
polypyrimidine tract is usually preferred to others (Reed,
1996). We also proposed a hypothesis that this noncon-
sensus branchpoint region was the cause of inefficient
debranching, leading to the accumulation of the LAT
lariats. Thus, as explained below, we next used mutagen-
esis to test whether by introducing better branchpoint
sequences could make the lariats better substrates for
debranching and abolish their accumulation.
To facilitate mutagenesis in the predicted branchpoint
region, we made a construct in which a 2.4-kb fragment
of the HSV-1 genome, spanning the 2.0-kb LAT region,
was inserted into the multiple cloning site of the eukary-
otic expression vector pSVL. This construct was then
used to make two mutants, A and B, which had changes
in the predicted 7-nt branchpoint region (Fig. 1B) to
improve the match to 6/7 and 7/7, respectively. The wild
type and mutants were each transfected into cultured
cells and after 3 days total RNA was harvested for anal-
yses. By 3% agarose gel electrophoresis and Northern
blot with a LAT-specific probe, we examined whether the
2.0 LAT accumulated in the transfected cells. Our previ-
ous experience with such an analysis of RNA from both
productively and latently infected cells was that the
2.0-kb LAT RNA could thus be resolved into two bands.
The slower species was characterized as a nonlinear
species and interpreted as the 2.0-kb LAT lariat (Wu et
al., 1996). It also migrated more slowly than expected
relative to linear DNA size markers. The faster species
was identified as the single-nicked form of the lariat.
As shown in Fig. 2 lane 4, we detected two predomi-
nant bands for cells transfected with the wild-type con-
struct. These bands were not detected in nontransfected
cells (lane 3) and were of comparable mobility to those
detected in productively infected CV-1 cells (lane 2). We
thus identify the slower species as the 1954-nt lariat and
indicate it as 1954-L. The faster species we identify as
the single-nicked form of the lariat and indicate it as
1954-NL. (This nicking probably occurs during or after
RNA isolation since, inside the cell, we would expect
nicked lariats to be promptly degraded by host exonucle-
ases.) These data are consistent with the interpretation
that, in the absence of virus infection, the 2.0-kb LAT was
spliced out and accumulated in a lariat conformation.
In contrast to cells transfected with the wild-type se-
quence, cells transfected with either mutant A or B (lanes
5 and 6, respectively) failed to show any detectable
LAT-specific species. For the two mutants this apparent
lack of LAT species could have been due to a reduced
level of synthesis or to an increased level of debranching
followed by degradation. To distinguish between these
possibilities we further examined other possible RNA
species generated from the LAT expression constructs
during the DNA-directed transcription and subsequent
RNA processing.
One advantage of using the pSVL expression cassette,
as represented in Fig. 3, was that this vector contained
an SV40 late promoter to produce transcripts with an
SV40 59 leader and the VP1 intron. Since the primary
transcripts had both an SV40 and a LAT intron, it was
FIG. 1. Sequence elements involved in splicing of the 2.0-kb LAT. In A the consensus splice donor, splice acceptor, and branchpoint region
sequences are from Moore et al. (1993). The HSV-1 LAT splice donor and acceptor sequences are from Farrell et al. (1991). The LAT sequence is
numbered with the splice acceptor site as 21. The 7-nt predicted branchpoint region (224 to 230) is indicated by shading. Another potential
branchpoint nucleotide at 229 is also shown. The asterisks indicate nucleotides in the HSV-1 sequences that are in disagreement with the splicing
consensus. B shows the two mutant branchpoint sequences, A and B, which transform the wild-type HSV-1 sequence and its 3/7 match with the
consensus to 6/7 and 7/7, respectively.
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possible to compare the splicing for these two introns.
The primary transcripts could be polyadenylated via an
SV40 poly(A) signal. Figure 3 summarizes possible un-
spliced and spliced RNA products, and their expected
sizes, when the LAT cassette was expressed and pro-
cessed. (The 1.5-kb LAT lariat is not shown since as
described later, it was not detected in these transient
transfection experiments.)
The Northern analyses of RNAs from transfected
cells are shown in Fig. 4. We transfected Huh7 cells
with the three pSVL constructs containing the 2.0-kb
LAT region that were either wild type (lane 6) or mutant
A (lane 7) or B (lane 8). Prior to Northern analyses of
these RNAs we separated nonpolyadenylated RNA
(Fig. 4A) from polyadenylated RNA (Fig. 4B). In Fig. 4A
the probe L was specific for the LAT intron region; in
Fig. 4B the probe M was specific for the 39 exon region
adjacent to the 2-kb lariat region. In addition to two
sets of size standards (lanes 1 and 2) we used TGG
RNA from latently infected mice (lane 4), as standards
for the 2.0-and 1.5-kb LAT lariats. And finally, we used
an HSV-1 RNA (Fig. 4, lane 3), as transcribed in vitro,
as a standard to allow quantitation between Figs. 4A
and 4B. We were thus able to identify and quantitate
each of the detected RNA species and to determine
the upper limits of expression for those that were not
detected. Our interpretation of these data, normalized
relative to the amount of HSV 2.0-kb LAT made by the
wild-type cassette, is summarized in Fig. 3.
Consider first RNA expression in cells transfected
with the wild type construct. The nonpolyadenylated
2.0-kb LAT lariat (1954-L) was detected and, on a molar
basis, was the most abundant. The 1.5-kb LAT lariat
was not detected (,3% relative to 2.0-kb lariat). There
were four polyadenylated species present in detect-
able amounts. These were identified according to their
sizes and probe hybridization, as indicated in Figs. 3
and 4B. There were significant amounts of a doubly
spliced 726-nt species and of a 522-nt species that
was interpreted as an alternatively spliced product
using the VP1 splice donor and the HSV-1 splice ac-
ceptor. Less abundant were a 1693-nt singly spliced
and a 3647-nt unspliced species. The predicted
2680-nt singly spliced RNA was not detected. These
data indicate that the LAT intron was more efficiently
spliced from the primary transcripts than the SV40 VP1
intron. Note that only splicing to produce the 1693- and
726-nt polyadenylated species could also generate the
2.0-kb lariat. The total abundance for these two spe-
cies was only somewhat less than that for the lariat;
that is, they were not much less stable than the lariat.
These data for expression from the wild-type se-
quence were then compared with the observations for
the mutants A and B. In cells transfected with either of
these mutants, the level of any of the polyadenylated
species was comparable to that in wild-type transfected
cells. The only dramatic difference was at least a 90-fold
decrease in the amount of the 2.0-kb lariat (1.1 and 0.6%)
relative to wild type (100%). Taken together, these muta-
tions we made in the predicted branchpoint regions had
no effect on the efficiency of splicing and polyadenyla-
tion; rather, they reduced the accumulation of the 2.0-kb
LAT lariat.
Determination of branchpoint nucleotide
During the course of our study, Zabolotny et al. pub-
lished evidence obtained by an RT–PCR procedure for a
branchpoint quite different from our prediction (Zabolotny
et al., 1997). Their site was a guanosine, located 75 nt 59
of the splice acceptor site. Because of the discrepancy in
the position of the branchpoint nucleotide, we applied
the following two strategies to independently determine
the branchpoint nucleotide.
FIG. 2. Northern analysis of LAT-related RNAs expressed in trans-
fected Huh7 cells. RNA was extracted at 3 days after transfection.
Samples were glyoxalated prior to electrophoresis into a 3% agarose
gel. Northern analysis was with LAT-specific probe P, as indicated in
Fig. 3. Lane 1 is a DNA size marker, with sizes indicated at the left side.
Lane 2 is a positive control of RNA from productively HSV-1 infected
CV-1 cells, with the positions of the 1954-nt lariat (1954-L) and the
nicked lariat (1954-NL) indicated at the right side. Lanes 3–6 are RNAs
from Huh7 cells at 3 days after transfection with the following pSVL
constructs: lane 3, unmodified pSVL; lane 4, pSVL containing the 2.4-kb
HSV LAT cassette; lane 5, as in lane 4 but with mutation A in the
predicted branchpoint region; lane 6, as in lane 4 but with mutation B
in the same region. Lane 4 contains not only species that comigrate
with 1954-L and 1954-NL but also relatively minor amounts of unchar-
acterized species of faster mobility, even faster than expected for a
1954-nt linear RNA, but not as fast as for 1.5-kb LAT lariats.
142 WU ET AL.
The first strategy provided evidence that the major
branchpoint nucleotide was not at position 275. As dia-
grammed in Fig. 5A, the approach was to hybridize one
or more oligonucleotides to the RNA from infected CV-1
cells and then follow the consequences of digestion with
RNaseH by Northern analysis using a LAT-specific
probe. Oligonucleotide Q was designed to hybridize to
241 to 252 on the LAT RNA. RNaseH digestion after
such hybridization with Q converted the lariat species,
1954-L, to the position of nicked lariats, 1954-NL (Fig. 5B,
lane 4). This conversion should not occur if the branch-
point was at a site 59 of Q, such as at 275. As one control
we showed that for RNaseH digestion in the absence of
oligonucleotide, there was no such conversion (Fig. 5B,
lane 2). As another control we tested oligonucleotide P,
spanning 2518 to 2539, and it gave products of the
same size as obtained with Q (Fig. 5B, lane 3). In order to
confirm that the digestion with Q was site-specific we
next carried out digestions following hybridization to
both P and Q. Examination of this RNA showed the
disappearance of both 1954-L and 1954-NL and the ap-
pearance of two novel bands corresponding to linear
RNAs of about 1496 and 483 nt (Fig. 5B, lane 5). These
two new bands are consistent with the interpretation
shown in Fig. 5A. In contrast to our observations, if the
branchpoint were 59 of Q, such as at 275, oligonucleo-
tide Q would hybridize to the tail of the lariat and so a
double digestion with P and Q would give a product
similar to those of the nicked lariats, with the size almost
the same as that of 1954-NL.
The above RNaseH studies showed that the majority
of LAT lariats use a branchpoint(s) that is(are) between
252 and the known splice acceptor. Our second strategy
was to use primer extension in an attempt to determine
the actual branchpoint nucleotide(s). The strategy, as
shown in Fig. 6A, was to hybridize a 59-labeled 18-nt
primer to the 39 end of the LAT lariat. Then, in primer
extension, reverse transcription should stop at the nu-
cleotide just before the branchpoint. When we applied
this strategy to RNA from infected CV-1 cells we detected
one prominent extension product (Fig. 6B, lane 1). Rela-
tive to an adjacent dideoxy-sequencing ladder, using the
same primer on a DNA template (Fig. 6B, lanes 2–5), we
deduce that the prominent band could correspond to the
adenosine at 229 as the branchpoint nucleotide. To
exclude the possibility that this prominent band was
caused by something other than a branchpoint, for ex-
ample secondary structure in the RNA, we tested primer
extension on linear RNA, as transcribed in vitro. As
shown, we detected many pause sites (Fig. 6B, lane 6).
However, none of these pauses corresponded to that
seen with RNA from infected CV-1 cells. Thus, we are
FIG. 3. Predicted and observed expression and processing of HSV LAT sequences in transfected cells. Theoretically, RNA transcribed from pSVL
containing the 2.4-kb LAT cassette can undergo various RNA processing events including 39 polyadenylation, splicing of either the SV40 VP1 intron
and/or the LAT 2.0-kb intron, alternative splicing from the VP1 splice acceptor to the LAT splice donor, and also accumulation of spliced out sequences
as stable lariats. Some of these processed RNAs are indicated along with their expected sizes, excluding poly(A), if present. The relative abundances,
as summarized at the right, are derived from the Northern data presented in Fig. 4. This includes data not only for the wild-type LAT cassette but
mutants A and B, as indicated in Fig. 1. Region-specific probes L and M, as used in Northern analyses, are indicated at the bottom of the figure.
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more confident that the adenosine at 229 corresponds
to a branchpoint. We cannot exclude that there may be
other relatively minor sites. And, of course, this site is not
the adenosine at 225, which we initially predicted.
As part of this primer extension study we also exam-
ined RNAs that had been first hybridized with oligonu-
cleotide Q and then digested with RNaseH. We observed
that this had no effect on the primer extension products
determined for the RNA from infected CV-1 cells (data not
shown). This was expected since oligonucleotide Q
should hybridize to a region more 59 of the branchpoint
and so reverse transcription would encounter the
branchpoint before this region where RNaseH cleavage
occurred. In contrast, it had a major effect on the prod-
ucts obtained with the linear RNA synthesized in vitro
(Fig. 6B, lane 7). We now detected prominent bands
corresponding to the middle of where Q would hybridize,
presumably because reverse transcription now arrested
at sites where RNaseH cleaved. Thus, for the earlier
RNaseH study (Fig. 5) we can now interpret the branch-
point as being no further away than 246, relative to the
splice acceptor site.
LAT expression in transfected Huh7 and NA cell lines
In our transient transfection studies using Huh7 cells,
the 1.5-kb LAT was not detected (Fig. 4A), nor is it de-
tected in a productive infection which lyses cells within
24 h (Spivack et al., 1991; Wu et al., 1996). In contrast, we
know that this species is almost as abundant as the
2.0-kb lariat in RNA from the TGG of latently infected
mice (Wu et al., 1996). One hypothesis is that the splicing
to generate 1.5-kb lariats is neuron-specific and occurs
only in cells of neuronal origin. This is not unreasonable
since there are ample precedents for neuron-specific
splicing of cellular transcripts (Leff et al., 1987; Black,
1992; Zhang et al., 1996). We therefore compared expres-
sion of the LAT cassette in transfected neuronal vs non-
neuronal cells.
The Northern analyses of such experiments are
shown in Fig. 7. We were not able to detect the 1.5-kb LAT
(,4%) in either nonneuronal cells, Huh7, or neuronal
cells, NA, at times up to 6 days after transfection. We also
looked at productively infected NA cells with HSV-1 but
only detected the 2.0-kb LAT (data not shown). Therefore,
FIG. 4. Northern analysis of RNAs detected in transfected Huh7 cells. RNA was extracted at 3 days after transfection. Samples were glyoxalated
prior to electrophoresis into a 1.5% agarose gel. Northern analysis was with either LAT-specific probe L (A) or 39-exon-specific probe M (B), as
indicated in Fig. 3. Lanes 1 and 2 are DNA and RNA size markers, respectively, with sizes indicated at the left side. Lane 3 is a hybridization standard
of RNA transcribed in vitro, spanning the sequences from the pSVL promoter through the 2.4-kb LAT region. Lane 4 is a positive control of RNA
extracted from the TGG of latently infected mice. Lanes 5–8 are nonpolyadenylated RNAs from untransfected or transfected with wild type or mutant
A or mutant B, respectively. B only shows lanes 59–89, which are the poly(A)-containing RNAs isolated from the same transfected cells as the
nonpolyadenylated RNAs analyzed in lanes 5–8. At the right side of A are indicated identifications of 1954-L and 1395-L based upon the TGG standard.
The 3125-L species is considered in the Discussion. At the right side of B are indicated, as predicted in Fig. 3, the sizes not including the length of
the poly(A) tails.
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in order to test the expression of the 1.5-kb LAT, we had
to return to the animal model.
LAT accumulation during establishment of latency in
infected mice
We infected 24 mice and they were sacrificed through-
out a 30-day period. At each time point 3 animals were
sacrificed and then the TGG were excised and pooled.
RNAs isolated from each pool were subjected to North-
ern analyses. As shown in Fig. 8, we found that signifi-
cant amounts of the two lariat species were clearly
detected by 10 days. At earlier times the amounts were
either relatively low (day 5) or undetectable (days 1, 3,
and 7).
From 10 to 30 days the two lariats were readily detect-
able. Quantitation showed that the molar ratio of small to
large LAT increased with time as 0.14, 0.26, 0.42, and 0.63
for days 10, 13, 20, and 30, respectively. Three explana-
tions for this time dependence are considered in the
Discussion.
DISCUSSION
We and others have previously provided evidence to
support the interpretation that the 2.0-kb LAT intron ac-
cumulates mainly in a lariat conformation (Wu et al.,
1996; Rodahl and Haarr, 1997). Initially we predicted the
adenosine at 225, closest to the polypyrimidine tract, to
be the branchpoint and changed the surrounding se-
quence to test the hypothesis that a nonconsensus
branchpoint region was responsible for inefficient de-
branching of the LATs (Fig. 1). During the course of our
study, others have published results indicating that by
using an RT–PCR procedure they identified the branch-
point as a guanosine at 275 and pointed out the exis-
tence of a strong hairpin region, 272 to 221 (Krummen-
acher et al., 1997; Zabolotny et al., 1997). We therefore
used two alternative strategies to independently identify
the branchpoint. First, using oligonucleotide-directed
RNaseH cleavage we showed that the major branchpoint
of the 2.0-kb LAT was within 46 nt 59 of the splice
FIG. 5. Oligonucleotide-directed RNaseH digestion of LATs. A shows the strategy used to map the branchpoint nucleotide. Included are the
sequence and relative position for each of the oligonucleotides P and Q. The 2.0-kb lariat is depicted using the predicted branchpoint at position 225
(relative to the splice acceptor site as 21), as indicated by A. The asterisk indicates the guanosine at position 275, which has also been interpreted
as the branchpoint nucleotide (Zabolotny et al., 1997). Our strategy was to submit the lariat RNA by a combination of oligonucleotide-directed RNaseH
digestions, followed by detection using Northern analysis. As described in the text, the consequences of such digestions directed by oligonucleotides
P and/or Q allowed an approximate localization of the branchpoint nucleotide. The expected size of the smaller product from RNaseH digestion with
both oligonucleotides is 483 nt. B shows the Northern analysis with a probe spanning the 2.0-kb LAT. RNA from infected CV-1 cells was hybridized
with no oligonucleotides (lane 2) or oligonucleotide P (lane 3) or Q (lane 4) or both (lane 5) and then digested with RNaseH. The products were
assayed by Northern analysis. Lane 1 is the DNA marker with sizes indicated at the left. At the right side are indicated the 2.0-kb lariat, 1954-L, and
the single-nicked lariat, 1954-NL. Also shown are the deduced sizes of the two fragments released in lane 5 by the RNaseH digestion following
hybridization with both P and Q.
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acceptor (Fig. 5). Second, by primer extension we lo-
cated the branchpoint as the adenosine at position 229,
close to but different from our initial prediction of the
adenosine at 225 (Fig. 6). The discrepancy among the
three methods might be due to the fact that the strong
secondary structure (272 to 221) somehow interferes
with the RT–PCR procedure and leads to misidentifica-
tion of the nucleotide at 275 as the branchpoint.
In the first part of our study we made mutations in the
flanking sequence of the adenosine at 225 to improve
the match with the consensus splicing branchpoint re-
gion. Although later on in this study we showed that this
adenosine at 225 was actually not the branchpoint for
the 2.0-kb lariats, our mutagenesis studies did give in-
teresting results; that is, no significant changes in the
splicing efficiency were observed and yet the accumu-
lation of the 2.0-kb LAT was reduced at least 50-fold. Our
original interpretation for this instability of the 2.0-kb LAT
generated from the mutant expression cassettes was
that these lariats were efficiently debranched as a direct
effect of using a 7-nt branchpoint sequence that was
more like the consensus. (In these mutant constructs we
expected but did not prove that the branchpoint nucleo-
tide was the adenosine at 225, both because of the
closer location to the pyrimidine tract and also because
this adenosine was now within a more optimal 7-nt
branchpoint sequence.) However, we later realized the
existence of a striking hairpin structure at 272 to 221
FIG. 7. Northern analysis of LAT-related RNAs expressed in trans-
fected Huh7 and NA cells. Samples were glyoxalated prior to electro-
phoresis into a 1.5% agarose gel. Northern analysis was with LAT-
specific probe L, as indicated in Fig. 3. Lanes 1 and 2 are DNA and RNA
size standards, respectively, as in Fig. 4, with the sizes indicated at the
left side. Lane 3 is a positive control of RNA from TGG of latently
infected mice, to locate the two major LAT species, 1954-L and 1395-L,
as indicated at the right side. Lanes 4–8 and 9–13 are RNAs extracted
at various times after transfection of Huh7 and NA cells, respectively,
with the LAT cassette. These samples were taken at various times after
transfection: lanes 4 and 9, day 1; lanes 5 and 10, day 3; lanes 6 and 11,
day 4; lanes 7 and 12, day 5; and lanes 8 and 13, day 6.
FIG. 6. Determination of 2.0-kb LAT branchpoint by primer extension.
A shows the primer extension strategy used. The LAT sequence is
numbered relative to the splice acceptor site as 21. An 18-nt primer
was 59 labeled and hybridized to RNA from infected CV-1 cells. The
expected hybrid should be extended with reverse transcriptase to the
nucleotide immediately prior to the branchpoint nucleotide. The
branchpoint nucleotide identified by primer extension is the adenosine
at position 229, indicated by a dot. B shows the sequencing gel
analysis which identified the branchpoint nucleotide. Lane 1 is primer
extension on RNA harvested from infected CV-1 cells (indicated above
as CV-1 RNA). Lanes 2–5 are sequencing ladders (indicated above as
C, T, G, and A) obtained using the 59-labeled 18-nt primer, cloned HSV-1
DNA as template, and Sequenase. Lanes 6 and 7 are primer extensions
on in vitro transcribed RNA spanning the 2.0-kb LAT region. The
difference is that prior to primer extension in vitro transcribed RNA
used in lane 7 (indicated above as 1) was hybridized to oligonucleotide
Q and subjected to RNaseH digestion; RNA in lane 6 (indicated above
as 2) was without such a treatment. In lane 1 the primer extension
product is indicated with a dot and the deduced sequence extension is
shown at the left side. At the right side is indicated the region deduced
from the sequencing ladder, where oligo Q would hybridize. Also
indicated, by an asterisk, is the position of a band present in lanes 1, 6,
and 7. Because this band also appeared in a reaction without reverse
transcriptase (data not shown), we interpreted it as a contaminant of
the primer preparation.
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(Zabolotny et al., 1997) and thus proposed that an addi-
tional factor contributing to the increase in debranching
might be the disruption of a secondary structure that was
inhibiting efficient debranching.
This interpetation of our mutagenesis data may pro-
vide insights as to why the wild-type LAT lariats fail to be
debranched. It may not be just because the sequence
flanking the branchpoint at 229 is only a 4/7 match with
the consensus. An additional factor could be the hairpin
structure. That is, once the lariat was generated during
splicing this secondary structure (which is located 272
to 221 and includes the branchpoint at 229) reformed
and interfered with debranching.
In our studies an important advantage of using the
pSVL vector to express the HSV-1 LAT sequences was
that we could compare the splicing of the 2.0-kb LAT with
that of VP1, the SV40 intron present at the 59 end of
primary transcripts. In terms of producing spliced prod-
ucts, the HSV sequences were more efficient than those
of SV40 (Figs. 3 and 4). In other words, at least under
these experimental conditions, even though the wild-type
LAT lariat failed to be debranched, the splicing of the
sequences was not compromised.
Intriguingly, there were even significant levels of what
we interpreted as alternative splicing, using the VP1
splice donor and the LAT splice acceptor (Figs. 3 and 4).
Such alternative splicing should use the branchpoint
sequence provided by the HSV lariat and therefore may
produce a novel stable lariat of 3125 nt. Closer examina-
tion of our data indicates that this probably did happen;
there was a nonpolyadenylated species of about this
size detected with the LAT probe (indicated as 3125-L in
lane 6 of Fig. 4A). Further experiments would be needed
to establish this interpretation.
The other focus of our studies was the origin of the
1.5-kb lariat. In previous studies using Northern analyses
of RNA from productively infected cells, we and others
have been able to detect the 2.0-kb lariat but not the
1.5-kb lariat (Spivack et al., 1991; Wu et al., 1996; Rodahl
and Haarr, 1997). We now find that the same is true in
transfected cells of both nonneuronal and neuronal ori-
gin (Fig. 7). A recent study with NA cells stably trans-
fected with HSV LAT sequences was also unable to
detect the 1.5-kb LAT by Northern analyses; however, it
was successful with a more sensitive (although not
quantitative) RT–PCR assay (Goldenberg et al., 1997). A
similar result was obtained in an earlier study using ND7
cells, another neuronal cell line (Mador et al., 1995). This
low abundance of the 1.5-kb species is quite unlike
latently infected TGG, where the 1.5-kb species can be
readily detected by Northern analysis and can be even
more abundant than the 2.0-kb species (Wu et al., 1996).
Thus, one explanation might be that although the NA cell
line can carry out some of the same splicing to produce
the 1.5-kb lariat, this splicing is much less than what
really occurs in neurons such as TGG. Also, there might
be other neuronal cell lines that are better systems for
studying neuron-specific splicing.
In our studies using Northern analyses, relatively large
amounts of the 1.5-kb species were detected in TGG only
at 10–30 days after infection (Fig. 8). We also observed
that during a time course following the establishment of
latency in TGG, there was a progressive change in the
molar proportion of 1.5-kb relative to 2.0-kb lariats (Fig. 8).
Between 10 and 30 days the value increased with time
more than fourfold (from 0.14 to 0.62). One interpretation
of why the 1.5-kb lariat seems to accumulate more with
time than the 2.0-kb would be that some of the 2.0-kb
species undergo further splicing, to remove the inner
intron, and produce the 1.5-kb lariat. This is less likely
based upon the precedents of other twintrons. Among
the chloroplast RNAs of Euglena there are 15 with twin-
trons, and there are data to support the argument that
after splicing of the outer intron there is no splicing of the
inner intron (Copertino and Hallick, 1993). Thus, in such
a model, the inner intron if it is to be spliced at all, is
spliced before or during the splicing of the outer intron,
but not after. A second interpretation might be that splic-
ing of the inner intron is not only neuron-specific but for
some reason the efficiency increases with time. Never-
theless, we prefer a third explanation that the smaller
FIG. 8. Northern analysis of LAT-related RNAs expressed in TGG of
mice at various times after initiation of infection. Samples were glyox-
alated prior to electrophoresis into 3% agarose gel. Northern analysis
was with LAT-specific probe L, as indicated in Fig. 3. Lane 1, DNA size
markers, with sizes indicated at right side. Lanes 2–9, RNA extracted
from TGG of mice at 1, 3, 5, 7, 10, 13, 20, and 30 days, respectively, after
corneal infection. The three lariat species are indicated at the right
side.
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lariat, once generated by neuron-specific splicing, is
more stable and accumulates more efficiently. Indirect
evidence support this interpretation that smaller lariats
are more stable than larger lariats. When various sizes of
nonreplicating circular RNAs related to hepatitis delta
virus, ranging in size from 0.35 to 1.7 kb, were produced
in transfected cells, the smaller circles were much more
stable (Lazinski and Taylor, 1994).
For the future, our findings using mutagenesis of a LAT
expression cassette make possible a novel way to knock
out the accumulation of LATs with minimal associated
changes in the HSV genome. Specifically, our mutant B,
which eliminated LAT accumulation, has only three nu-
cleotide changes relative to wild type and was actually
designed to preserve the open reading frame for ICP0.
Incorporation of this change onto an infectious genome
would allow a study of the consequences of LAT ablation
in the context of virus infection in an animal model.
Further mutagenesis studies might also help determine
whether the neuron-specific splicing of the inner intron to
produce the 1.5-kb LAT has any relevance for HSV-1
latency. The initial phase of such a study of neuron-
specific splicing by transfection of expression cassettes
into cultured cells would require a more sensitive assay
than Northern analysis, such as RT–PCR.
MATERIALS AND METHODS
Plasmids, probes, and primers
The 2.4-kb ApaI–ApaI fragment of HSV-1 DNA, span-
ning the 1954-nt LAT, was cloned at the ApaI site of the
multiple cloning region of the plasmid pGEMEX-2 (Pro-
mega). From such a construct the HindIII–BamHI frag-
ment was subcloned to pGEM4Z (Promega) to generate
an in vitro transcription vector and the XbaI–SacI frag-
ment was transferred into the eukaryotic expression vec-
tor pSVL (Pharmacia). In order to make an in vitro RNA
standard containing both SV40 and HSV-1 sequences, a
3.2-kb fragment was excised from the pSVL construct
and transferred into pGEM-4Z (Promega). For radioactive
probe production two subclones were made, one con-
taining about 500 nt of the LAT region and the other
containing about 150 nt of HSV-1 sequence between the
splice acceptor and the ApaI site.
The pGEM4Z construct containing the 2.4-kb LAT re-
gion was mutagenized using PCR and oligonucleotides
spanning the putative branchpoint region. Mutagenesis
was confirmed by nucleotide sequencing and then the
region was transferred into the pSVL construct as an
XbaI–SacI fragment.
Sequences of the oligonucleotides used in RNaseH
digestion and primer extension are shown in Figs. 5B
and 6A.
Transfection and infection of cultured cells
Huh7, a line of human hepatoblastoma cells (Nakaba-
yashi et al., 1982), and NA, a line of mouse neuroblas-
toma cells (McMorris and Ruddle, 1974), were trans-
fected with pSVL constructs using Lipofectamine ac-
cording to the recommendations of the manufacturer
(Gibco-BRL). Infections with HSV-1 were as previously
described (Wu et al., 1996).
Mouse infections
Female 4- to 6-week-old Balb/c mice (Jackson Labo-
ratory) were infected by corneal scarification with be-
tween 105 and 106 plaque-forming units (PFU) of HSV-1,
as previously described (Maggioncalda et al., 1994). At
each of a series of times out to 30 days, three mice were
sacrificed and the TGG excised.
RNA isolation and characterization
RNA was isolated from both tissue and cell culture
samples by a guanidine isothiocyanate procedure
(Chomczynski and Sacchi, 1987). For some experiments
polyadenylated RNA was then isolated using superpara-
magnetic beads to which oligo(dT) was attached (Dynal).
RNA was glyoxalated and subjected to either 1.5 or 3%
agarose gel electrophoresis and Northern analyses as
described (Fu and Taylor, 1993). RNA markers were tran-
scribed with a RiboMark labeling system (Promega). A
1-kb DNA ladder (Gibco-BRL) was 59 labeled using T4
kinase.
Oligonucleotide-directed RNaseH digestion and
primer extension
Either 10 ng of RNA transcribed in vitro from the
pGEM4Z construct or 1 mg RNA harvested from cells
infected with HSV-1 was hybridized with 5 pmol of oligo-
nucleotide P or Q, or both, in buffer containing 4.4 mg of
yeast tRNA, 20 mM Tris–HCl (pH 7.5), 10 mM MgCl2, and
100 mM KCl. The mixture was first heated at 95°C for 1
min and then incubated at 50°C for 15 min. Escherichia
coli RNaseH (Gibco-BRL) was then added to a final
concentration of 30 U/ml (or 120 U/ml in some cases) and
the reaction was carried out at 37°C for 45 min. The
products were precipitated with ethanol, glyoxalated,
and then analyzed on a 3% agarose gel as described
above. To determine the RNaseH digestion sites, the
products were first treated with 1 unit of RQ DNaseI
(Promega) to remove DNA oligonucleotides and then
subjected to primer extension.
Primer extension was carried out with 0.1 pmol of 59
32P-labeled 18-mer, as shown in Fig. 6A. Elongation
was at 48°C for 90 min in a 20-ml reaction containing
200 units reverse transcriptase (Superscript, Gibco-
BRL). Four dideoxy ladders were obtained by sequenc-
ing recombinant DNA with the same labeled primer
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using Sequenase (U.S.B.). These products were re-
solved on a 12% polyacrylamide sequencing gel con-
taining 7.5 M urea (Sambrook et al., 1989). After elec-
trophoresis the gel was analyzed using a phosphoim-
ager (Fuji).
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